Flood Law Group Comments on Recent AAICH Study

A study released August 1 highlights the challenges related to managing anticoagulant–associated intracerebral hemorrhage (AAICH).

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Our firm continues to investigate potential Xarelto lawsuits on behalf of individuals affected by serious bleeding events and their families in light of the latest findings.

Washington, D.C. (PRWEB) August 27, 2014

A recently published study by the Journal of Neurosurgery discusses the importance of time in correcting coagulopathy to prevent permanent injury or death. The study focuses on a variety of anticoagulants and examines medical conditions alleged to be caused by these drugs.

According to the research, although anticoagulants have been approved by the FDA to reduce the risk of stroke and systemic embolism, they are also known to affect the consistency of the anticoagulation effect and lead to serious problems including hemorrhage expansion, tissue damage and even death if not corrected immediately.

“The mortality rate due to AAICH is high despite anticoagulant reversal; it is as high as 42.3% to 67%,” notes the study, and is due in part to hemorrhage expansion, an alleged side effect of drugs like Warfarin and Xarelto. Moreover, AAICH cannot be reversed simply and, at the present time, there are no antidotes and no guide to treatment.

Despite this knowledge, the study notes that “use of anticoagulation therapy is increasing” and the approval of OAC therapies foreshadows wider use of oral anticoagulation and a growing concern for AAICH management. OACs like Xarelto have become more popular based on the absence of a need for routine monitoring and while this may seem like an advantage, it presents a concern in conditions where rapid anticoagulation reversal is needed.

National drug lawyers at Flood Law Group continue to investigate injury and death claims potentially linked to Xarelto and other anticoagulants.

“Results from the study parallel what plaintiffs have been arguing in Xarelto claims,” said Christopher Brown, Director of Communications for the practice. “Our firm continues to investigate potential Xarelto lawsuits on behalf of individuals affected by serious bleeding events and their families in light of the latest findings.”

About Flood Law Group

Flood Law Group, LLP is an experienced litigation firm, serving injured persons and families across the nation. The firm represents individuals that have been severely injured by negligence and handles cases involving personal injury, auto accidents, medical malpractice, defective medical devices and more. Flood Law Group, LLP is also one of the top law firms in the nation to handle serious injuries and wrongful death. For more information, please visit our website.


Contact

Follow us on: Contact's Google Plus